Gadolinium retention: a research roadmap from the 2018 NIH/ACR/RSNA workshop on gadolinium chelates
Gadolinium-based contrast agents (GBCAs) have revolutionized MRI, enabling physicians
to obtain crucial life-saving medical information that often cannot be obtained with other …
to obtain crucial life-saving medical information that often cannot be obtained with other …
Gadolinium-based contrast agents in kidney disease: a comprehensive review and clinical practice guideline issued by the Canadian Association of Radiologists
Purpose of review: Use of gadolinium-based contrast agents (GBCA) in renal impairment is
controversial, with physician and patient apprehension in acute kidney injury (AKI), chronic …
controversial, with physician and patient apprehension in acute kidney injury (AKI), chronic …
Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI)
RM Mann, A Athanasiou, PAT Baltzer… - European …, 2022 - Springer
Breast density is an independent risk factor for the development of breast cancer and also
decreases the sensitivity of mammography for screening. Consequently, women with …
decreases the sensitivity of mammography for screening. Consequently, women with …
Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium-based contrast agent: a systematic review …
SA Woolen, PR Shankar, JJ Gagnier… - JAMA internal …, 2020 - jamanetwork.com
Importance Risk of nephrogenic systemic fibrosis (NSF) to individual patients with stage 4 or
5 chronic kidney disease (CKD; defined as estimated glomerular filtration rate of< 30 …
5 chronic kidney disease (CKD; defined as estimated glomerular filtration rate of< 30 …
Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration
J Davies, P Siebenhandl-Wolff, F Tranquart… - Archives of …, 2022 - Springer
Gadolinium-based contrast agents (GBCAs) have transformed magnetic resonance imaging
(MRI) by facilitating the use of contrast-enhanced MRI to allow vital clinical diagnosis in a …
(MRI) by facilitating the use of contrast-enhanced MRI to allow vital clinical diagnosis in a …
Multicenter safety and practice for off-label diagnostic use of ferumoxytol in MRI
Background Ferumoxytol is approved for use in the treatment of iron deficiency anemia, but
it can serve as an alternative to gadolinium-based contrast agents. On the basis of …
it can serve as an alternative to gadolinium-based contrast agents. On the basis of …
Diffusion-weighted MRI for unenhanced breast cancer screening
N Amornsiripanitch, S Bickelhaupt, HJ Shin, M Dang… - Radiology, 2019 - pubs.rsna.org
Diffusion-weighted (DW) MRI is a rapid technique that measures the mobility of water
molecules within tissue, reflecting the cellular microenvironment. At DW MRI, breast cancers …
molecules within tissue, reflecting the cellular microenvironment. At DW MRI, breast cancers …
A systematic review of 639 patients with biopsy-confirmed nephrogenic systemic fibrosis
Background Although nephrogenic systemic fibrosis (NSF) affects the use of gadolinium-
based contrast agents (GBCAs) in MRI, there continues to be limited knowledge because of …
based contrast agents (GBCAs) in MRI, there continues to be limited knowledge because of …
Update on Gadolinium-Based Contrast Agent Safety, From the AJR Special Series on Contrast Media
Since its introduction more than 35 years ago, gadolinium-enhanced MRI has fundamentally
changed medical practice. Although extraordinarily safe, gadolinium-based contrast agents …
changed medical practice. Although extraordinarily safe, gadolinium-based contrast agents …
Systematic review of the literature: best practices
Reviews of published scientific literature are a valuable resource that can underline best
practices in medicine and clarify clinical controversies. Among the various types of reviews …
practices in medicine and clarify clinical controversies. Among the various types of reviews …